Back to Trades
Grant4
ROCKET PHARMACEUTICALS, INC.
RCKT
Total Value
$1.2M
Company Information
- Company Name
- ROCKET PHARMACEUTICALS, INC.
- Ticker Symbol
- RCKT
- CIK
- 0001281895
Insider Information
- Role
- Insider
- Location
- CRANBURY, NJ
Filing Details
- Filing Date
- Oct 8, 2025
- Transaction Date
- Oct 6, 2025
- Accession Number
- 0001140361-25-037683
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Oct 6, 2025 | Common Stock | 283,018 | — | Grant/Award | — |
| Oct 6, 2025 | Common Stock | 62,893 | — | Grant/Award | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Oct 6, 2025 | Derivative | 383,854 | $3.18 | Grant/Award | $1.2M |
Footnotes
- (F1)Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on October 6, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
- (F2)Represents RSUs that will vest in two installments. One-half (1/2) of the RSUs will become fully vested on October 6, 2026 and the remaining RSUs will vest on the second anniversary of the grant date, such that all of the shares underlying the award will be vested on the date two (2) years after the grant date, subject to the reporting person's continued employment with the Issuer or any of its subsidiaries.
- (F3)Represents non-qualified stock options ("NQSOs") that convert to common stock on a one-for-one basis. One-third (1/3) of such NQSOs will become fully vested on October 6, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.